• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ZIMMER BIOMET, INC. G7 ACETABULAR SYSTEM PPS LTD ACET SHELL 50D; PROSTHESIS, HIP

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ZIMMER BIOMET, INC. G7 ACETABULAR SYSTEM PPS LTD ACET SHELL 50D; PROSTHESIS, HIP Back to Search Results
Catalog Number 010000662
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Pain (1994); Bursitis (4832)
Date of Event 12/19/2024
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
(b)(4).D10: cat# 30123604 lot# 65257170 36mm i.D.Size d high wall liner.Cat# 802203602 lot# 3103134 femoral head 12/14 taper 36 mm diameter +0 mm neck length.Cat # 0106010202 lot# unk avenir, stem, standard, cemented, 2, taper 12/14.Cat# 47115003963 lot# ay30ac2103 optipac 60 refob bone cmt r-3.G2: foreign: denmark.The customer has indicated that the product will not be returned to zimmer biomet for investigation as it remains implanted.The investigation is in process.Once the investigation has been completed, a follow-up mdr will be submitted.
 
Event or Problem Description
It was reported a patient underwent an initial left total hip arthroplasty.Subsequently, the patient developed trochanteric bursitis approximately 21 months post-implantation.The patient was given a nerve block and prescribed pain medication and physical therapy.The event was reported resolved 3 months later, and all products remain implanted.Attempts have been made and no further information has been provided.
 
Event or Problem Description
No further information at the time of this report.
 
Additional Manufacturer Narrative
This follow-up report is being submitted to relay additional information.The following sections were {update/corrected} updated: g3; h2; h3; h6 bursitis is the inflammation or irritation of the bursae (the fluid filled sac that cushions the joint) and is typically caused by repetitive motion, overuse, and pressure to the bursae.Bursitis is a very common condition that can impact any of the joints and can last for a short duration or years.Symptoms the patient can experience include pain, tenderness, swelling, stiffness, decrease in movement, and/or redness at or around the joint that is involved.Conservative treatment consists of over the counter (otc) medications pain relievers and anti-inflammatories, rest, ice, elevation, and applying pressure wraps.If conservative treatments fail, physical therapy, aspiration, arthroscopy, or steroid injections may be necessary.The complaint indicates that postop bursitis developed and required medical intervention for treatment.Product has not been evaluated as it has been determined the event is not related to device.The root cause of the reported event was determined to be unrelated to the device.If any further information is found which would change or alter any conclusions or information, a supplemental will be filed accordingly.Zimmer biomet will continue to monitor for trends.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
G7 ACETABULAR SYSTEM PPS LTD ACET SHELL 50D
Common Device Name
PROSTHESIS, HIP
Manufacturer (Section D)
ZIMMER BIOMET, INC.
56 e. bell drive
p.o. box 587
warsaw IN 46581
Manufacturer (Section G)
ZIMMER BIOMET, INC.
56 e. bell drive
p.o. box 587
warsaw IN 46581
Manufacturer Contact
jennifer rapsavage
56 e. bell dr.
warsaw, IN 46582
5745260384
MDR Report Key23059166
Report Number0001825034-2025-02909
Device Sequence Number21177981
Product Code PBI
UDI-Device Identifier00880304524217
UDI-Public(01)00880304524217(17)330112(10)7406405
Combination Product (Y/N)N
Initial Reporter CountryDA
PMA/510(K) Number
K121874
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2023
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Study,Company Representative
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date (Section B) 12/23/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Lay User/Patient
Device Catalogue Number010000662
Device Lot Number7406405
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 08/26/2025
Supplement Date Received by Manufacturer12/22/2025
Initial Report FDA Received Date09/15/2025
Supplement Report FDA Received Date12/23/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured01/12/2023
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
SEE H11 NARRATIVE.
Outcome Attributed to Adverse Event Other;
Patient SexFemale
Patient Weight89 KG
-
-